EXPAREL for Minimally Invasive Supracervical Hysterectomies

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Pain
Interventions
DRUG

Saline Solution for Injection

Injection of 20mL of 0.9%Normal Saline

DRUG

Exparel

Exparel (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic, indicated (bupivacaine liposome injectable suspension) for administration into the surgical site to produce postsurgical analgesia.

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER